Innate Pharma
IPHA
#6986
Rank
$0.18 B
Marketcap
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)

Innate Pharma (IPHA) - Total debt

Total debt on the balance sheet as of December 2023 : $44.1 M

According to Innate Pharma 's latest financial reports the company's total debt is $44.1 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Innate Pharma - Total debt on balance sheet (from 2009 to 2023)

Total debt by year

Year Total debt Change
2022-12-31$45.24 M-9.71%
2021-12-31$50.11 M113.46%
2020-12-31$23.47 M11.93%
2019-12-31$20.97 M305.44%
2018-12-31$5.17 M-26.51%
2017-12-31$7.03 M25.54%
2016-12-31$5.6 M36.62%
2015-12-31$4.1 M-19.76%
2014-12-31$5.11 M-23.14%
2013-12-31$6.65 M11.68%
2012-12-31$5.95 M-32.08%
2011-12-31$8.77 M-0.96%
2010-12-31$8.85 M-18.15%
2009-12-31$10.82 M21.55%
2008-12-31$8.9 M
2006-12-31$4.37 M538.01%
2005-12-31$0.68 M